Skip to main content
SpringerLink
Log in

Stiripentol

BCX 2600

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Perez J, Chiron C, Musial C, et al. Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia. 40: 1618–1626, Nov 1999

    Article  PubMed  CAS  Google Scholar 

  2. Chiron C, Marchand MC, Tran A, Rey E, STICLO study group, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. Lancet. 356: 1638–1642, 11 Nov 2000

    Article  PubMed  CAS  Google Scholar 

  3. Rey E, Tran A, d’Athis P, Chiron C, Dulac O, et al. Stiripentol potentiates clobazam in childhood epilepsy: a pharmacological study. Epilepsia. 40 (Suppl 7): 112–113, 1999

    Google Scholar 

  4. Farwell JR, Anderson GD, Kerr BM, et al. Stiripentol in atypical absence seizures in children: an open trial. Epilepsia. 34: 305–311, Mar–Apr 1993

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stiripentol. Drugs R&D 3, 220–222 (2002). https://doi.org/10.2165/00126839-200203030-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203030-00019

Keywords

Search

Navigation